With the increase in frequency of disasters, there is a need to improve early warning systems (EWS) for EA to reduce the risks faced by children and their families. As a consequence, the term early warning, early action (EWEA) has become increasingly common among those responding to slow-onset disas...ters.
more
Health and Human Rights Journal
December 2016 / Volume 18 / Number 2 / Papers, 171-182
Harm Reduction Journal (2016) 13:28
DOI 10.1186/s12954-016-0118-x
PQDx 0197-045-00 WHO
PQDx PR
March /2016, version 2.0
UNAIDS 2016 / Meeting Report
Lessons from the IRC’s Early Emergency Response in the Urban Areas of Lesbos between September 2015 and March 2016
Indicators are a representation of reality. They are just numbers on a piece of paper or on a computer screen, but they stand for something far greater – the success of your project. Indicators are usually defined in the context of project planning and show something about or give an indication of... progress towards realising the project goal, without being complete or comprehensive. Of course, there could be other representations of this reality, such as stories (Dart and Davies, 2003) or drawings (Feuerstein, 1986) or photographs (Tijm et al, 2011). However, indicators are a widely accepted way of representing what is being achieved in a programme or project.
more
Regional Tuberculosis Program, Pan American Health Organization (PAHO/WHO)
Research Article
PLOS ONE | DOI:10.1371/journal.pone.0164619 October 13, 2016
The primary role of Benin’s Department of Pharmacy and Medicines (DPMED) is to develop and apply the national pharmaceutical policy. The main objective of this policy is to ensure the availability and accessibility of quality medicines for the population. To fulfill its mandate, DPMED aims to stre...ngthen its regulatory capacity, including the issuance of licenses to pharmaceutical establishments and the registration of pharmaceutical products. Benin’s current registration system shares core concerns that are common to most developing countries, notably the capacity to evaluate and monitor the security, efficacy, and quality of medicines and other health products. It is currently characterized by 1) poor or inadequate traceability of records or regulations (example: a product’s marketing authorization [MA] is often hard to find); 2) lack of evidence used in the regulatory decision-making process (reasons behind special import authorization, i.e., products without valid MAs); 3) inconsistent and unsecured archiving system; 4) limited human resources; and 5) an inefficient information management system
more